Publication | Closed Access

Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis

InflammationCytokineMucosal ImmunologyImmunologyMurine ColitisAutoimmunityHumoral ImmunityCd4 T Cell ResponsesUlcerative ColitisRecombinant VaccinesImmunotherapyMedicineIl-12/il-23 P40